Transparency: Tapping the crowd
Transparency using crowdsourcing, telemedicine for clinical trials; MS is first
Transparency Life Sciences LLC is aiming to run better, cheaper clinical trials by tapping into the collaborative intelligence of stakeholders to design its studies and using telemedicine to capture data and improve enrollment.
While the company ultimately plans to in-license or acquire new compounds, it initially is repurposing generics to see if the approach can work, beginning in multiple sclerosis.
CEO and co-founder Tomasz Sablinski said most clinical trials are designed with the help of a handful of key opinion leaders. Transparency thinks